Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

eZono appoints Cox CEO

This article was originally published in Clinica

Executive Summary

German tablet ultrasound system developer eZono has made ultrasound industry veteran Graham Cox CEO, effective 1 June. He will succeed co-founder and acting CEO Allan Dunbar, who will stay with the company as chief commercial officer. Mr Cox previously worked for another ultrasound specialist, SonoSite, for 13 years, most recently as vice-president, worldwide sales and distribution. SonoSite was acquired by Fujifilm in 2011 (www.clinica.co.uk, 15 December 2011). Before this, he had senior positions at ATL Ultrasound (which Philips acquired in 1998, www.clinica.co.uk, 3 August 1998) and Acuson (which Siemens acquired in 2000, www.clinica.co.uk, 2 October 2000). Privately-held eZono’s first-generation product, the eZono 3000, is CE marked for sale in Europe and gained US FDA 510(k) clearance in July 2011. The Jena-based firm’s ultrasound devices are aimed at the point-of-care market.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT100371

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel